was no change in the expression of the basolateral iron-transport molecules Iregl and hephaestin. After FCA administration, hepatic hepcidin levels increased, confirming the inverse relationship between hepcidin and transporter expression observed in the dietary-switch experiment. In the case of APR, however, hepcidin expression changed more rapidly (peaking at 8 h following FCA treatment and returning to normal levels by 48 h) than the expression of iron transporters. The increase also preceded the decline in plasma transferrin saturation, suggesting that hepcidin activation may be a primary event.
FCA treatment and returning to normal levels by 48 h) than the expression of iron transporters. The increase also preceded the decline in plasma transferrin saturation, suggesting that hepcidin activation may be a primary event.
Conclusions
Each of the studies described above demonstrates a close inverse relationship between the expression of hepcidin in the liver, iron transporters in the duodenum and iron absorption. The data also indicate that changes in each of these parameters can occur before any alteration in the level of hepatic storage iron or any overt changes in haematological parameters. The only plasma parameter that we measured that reflected these changes was the transferrin saturation, but whether it plays a causative role or simply reflects changes in iron supply to the plasma could not be determined. Our data provide strong circumstantial evidence in support of the proposal that hepcidin is a signalling molecule that acts as a negative regulator of iron absorption. They suggest that hepcidin activation is an early event and that the peptide subsequently acts on the intestinal epithelium to alter the expression of irontransport molecules. However, the mechanism by which this might be achieved has yet to be resolved. in liver biopsies from HH patients showed that the protein is completely absent or markedly reduced in heavily iron-loaded H H patients. Real-time PCR was then conducted in an attempt to investi-gate the mRNA levels and establish the underlying mechanism behind the disappearing act of I R P l . T h e two possibilities are : transcriptional regulation (through the inhibition of transcription) or post-transcriptional regulation (either through increased turnover of protein or inhibition of translation) of IRPl . Preliminary data suggest that transcription of IRPl is not affected by chronic iron overload, and down-regulation may be attributable instead to degradation of the protein.
Introduction
In hereditary haemochromatosis (HH), a genetic condition of iron overload affecting approx. 1 in 300 individuals, with 1 in 8-10 being carriers, accumulation of iron in parenchymal tissues, including the liver, occurs [l-31. T h e candidate gene for HH, the HFE gene, was identified in 1996 through a positional cloning approach and the most common mutation in patients with HH results in a cysteine-to-tyrosine substitution at amino acid 282 (C282Y) [4] . Six years after the discovery of the HFE gene, it still remains unclear how iron accumulates in the liver. Since expression of the transferrin receptor is decreased in that tissue, a dysfunctional iron-regulatory protein 1 ( I R P l ) might be the molecular clue to the iron overloading that characterizes the disease. I R P l is a bifunctional protein that can act either as a cytoplasmic aconitase or as an iron-responsive element (IRE)-binding protein [S] . T h e RNAbinding activity of IRPl is regulated posttranslationally by the insertion or extrusion of a 4Fe-4S cluster, without changes in the levels of protein [6] . Investigation of I R P l expression in liver biopsies from HH patients, by immunohistochemistry and Western blotting, showed that the protein is completely absent or markedly reduced in heavily iron-loaded HH patients. T h e underlying mechanism behind the disappearing act of I R P l was investigated by real-time PCR. Preliminary data suggest that transcription of IRPl is not affected by chronic iron overload, and down-regulation may be attributable instead to degradation of the protein.
haem Fe/g of dry weight of liver and had undergone liver biopsy for other indications. Biopsies with a hepatic iron concentration in the range of 2000-800Opg of non-haem Fe/g of dry weight of liver were considered mild iron-overload cases, while those in the range of 8000-30000 pg of nonhaem Fe/g of dry weight of liver indicated heavy iron overload. Immunostaining was performed on 10 sections from five patients who had undergone venesection to restore iron levels to normal (two sections from each patient representing the before and after venesection states). Western blotting was carried out on five samples (two controls, one mild case and two heavily iron-loaded cases) and the results were reproduced several times. T h e levels of I R P l mRNA were assessed by real-time PCR in a total of 12 samples (five controls, five heavy cases and two mild) using IRP1-specific primers and expressed in ratios with human p-actin mRNA as a control.
Results and discussion
T h e results of immunohistochemistry (Figure 1 
Materials and methods
T h e levels of IRPl were assessed by immunohistochemistry and Western blotting of liver biopsy specimens in both normal and heavily iron-loaded subjects using antisera that have been described previously [7, 8] . Control liver samples were obtained from patients that had a hepatic iron concentration of less than 2000pg of non-
Figure 2
Western blotting of liver samples
Western blotting was performed with rabbit anti-peptide A of human IRP I antibody against 2 pg of protein from liver samples from two control patients (lanes I and 2), one H H patient with mild iron loading (lane 3), and two HH patients with heavy iron loading (lanes 4 and 5). IRPl is an RNA-binding protein that posttranscriptionally modulates the expression of mRNAs encoding proteins involved in iron homoeostasis. It is well established that the RNA-binding activity of IRPl is regulated posttranslationally by the insertion or extrusion of a 4Fe-4S cluster, without changes in IRPl levels.
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However, the possibility of an alternative mechanism of regulation of this protein is suggested from findings that under extreme iron-loading conditions, as in HH, the levels of the protein decrease. The results of the present study confirm a down-regulation of IRPl under conditions of heavy iron loading and suggest control either at the level of translation or turnover of IRPl protein. There is no known mechanism by which translation of IRPl would be selectively inhibited under stress induced by iron overload. There have been reports of iron-induced degradation of IRPl, which is thought to involve haem [lo] . However, the molecular mechanism by which iron can induce IRPl breakdown remains unclear.
